260 related articles for article (PubMed ID: 15117950)
1. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
Kassenbrock CK; Anderson SM
J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950
[TBL] [Abstract][Full Text] [Related]
2. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor.
Lill NL; Douillard P; Awwad RA; Ota S; Lupher ML; Miyake S; Meissner-Lula N; Hsu VW; Band H
J Biol Chem; 2000 Jan; 275(1):367-77. PubMed ID: 10617627
[TBL] [Abstract][Full Text] [Related]
3. Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.
Nadeau SA; An W; Mohapatra BC; Mushtaq I; Bielecki TA; Luan H; Zutshi N; Ahmad G; Storck MD; Sanada M; Ogawa S; Band V; Band H
J Biol Chem; 2017 Mar; 292(9):3666-3682. PubMed ID: 28082680
[TBL] [Abstract][Full Text] [Related]
4. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment.
de Melker AA; van der Horst G; Borst J
J Biol Chem; 2004 Dec; 279(53):55465-73. PubMed ID: 15465819
[TBL] [Abstract][Full Text] [Related]
6. c-Cbl-mediated ubiquitinylation is required for epidermal growth factor receptor exit from the early endosomes.
Ravid T; Heidinger JM; Gee P; Khan EM; Goldkorn T
J Biol Chem; 2004 Aug; 279(35):37153-62. PubMed ID: 15210722
[TBL] [Abstract][Full Text] [Related]
7. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
[TBL] [Abstract][Full Text] [Related]
8. The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme.
Ryan PE; Sivadasan-Nair N; Nau MM; Nicholas S; Lipkowitz S
J Biol Chem; 2010 Jul; 285(31):23687-98. PubMed ID: 20525694
[TBL] [Abstract][Full Text] [Related]
9. The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase.
Ota S; Hazeki K; Rao N; Lupher ML; Andoniou CE; Druker B; Band H
J Biol Chem; 2000 Jan; 275(1):414-22. PubMed ID: 10617633
[TBL] [Abstract][Full Text] [Related]
10. Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases.
Kowanetz K; Crosetto N; Haglund K; Schmidt MHH; Heldin CH; Dikic I
J Biol Chem; 2004 Jul; 279(31):32786-95. PubMed ID: 15159412
[TBL] [Abstract][Full Text] [Related]
11. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7.
Yokouchi M; Kondo T; Houghton A; Bartkiewicz M; Horne WC; Zhang H; Yoshimura A; Baron R
J Biol Chem; 1999 Oct; 274(44):31707-12. PubMed ID: 10531381
[TBL] [Abstract][Full Text] [Related]
12. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation.
Magnifico A; Ettenberg S; Yang C; Mariano J; Tiwari S; Fang S; Lipkowitz S; Weissman AM
J Biol Chem; 2003 Oct; 278(44):43169-77. PubMed ID: 12907674
[TBL] [Abstract][Full Text] [Related]
13. The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells.
Rao N; Lupher ML; Ota S; Reedquist KA; Druker BJ; Band H
J Immunol; 2000 May; 164(9):4616-26. PubMed ID: 10779765
[TBL] [Abstract][Full Text] [Related]
14. Requirements of multiple domains of SLI-1, a Caenorhabditis elegans homologue of c-Cbl, and an inhibitory tyrosine in LET-23 in regulating vulval differentiation.
Yoon CH; Chang C; Hopper NA; Lesa GM; Sternberg PW
Mol Biol Cell; 2000 Nov; 11(11):4019-31. PubMed ID: 11071924
[TBL] [Abstract][Full Text] [Related]
15. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a novel, transforming allele of the c-Cbl proto-oncogene from a murine macrophage cell line.
Bisson SA; Ujack EE; Robbins SM
Oncogene; 2002 May; 21(23):3677-87. PubMed ID: 12032836
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.
Qu X; Sada K; Kyo S; Maeno K; Miah SM; Yamamura H
Blood; 2004 Mar; 103(5):1779-86. PubMed ID: 14604964
[TBL] [Abstract][Full Text] [Related]
18. A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis.
Singh AJ; Meyer RD; Navruzbekov G; Shelke R; Duan L; Band H; Leeman SE; Rahimi N
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5413-8. PubMed ID: 17372230
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function.
Fong CW; Leong HF; Wong ES; Lim J; Yusoff P; Guy GR
J Biol Chem; 2003 Aug; 278(35):33456-64. PubMed ID: 12815057
[TBL] [Abstract][Full Text] [Related]
20. Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topography of substrate proteins to the c-Cbl TKB domain.
Sun Q; Jackson RA; Ng C; Guy GR; Sivaraman J
PLoS One; 2010 Sep; 5(9):e12819. PubMed ID: 20877636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
